Sterling
BioNTech logo
BioNTech
AstraZeneca logo
AstraZeneca

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: BioNTech 0.114, AstraZeneca 15.384.

BioNTech vs AstraZeneca Net Worth and Market Cap

BioNTech (BNTX) and AstraZeneca (AZN) are peers in Vaccines. BioNTech reported revenue of $114M as of Q2 2026, compared with $15.4B for AstraZeneca. AstraZeneca leads on revenue.

BioNTech's gross margin is 8.1% versus 83.6% for AstraZeneca. BioNTech's net margin is -777.3% versus 16.3% for AstraZeneca.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: AstraZeneca +6.4%, BioNTech -59.6%.
  • AstraZeneca made an operating profit in its latest quarter (20.6% margin); BioNTech made an operating loss (-897.8%).
  • BioNTech's KPIs on Sterling include Cash, Cash Equivalents, and Security Investments (Quarterly) and COMIRNATY Doses as Printed.
  • AstraZeneca's KPIs on Sterling include Alliance Revenue by Partnered Medicine (Quarterly) and AZD5004 + AZD6234 Trial Timeline: Oral GLP-1 + Oral Amylin.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, BioNTech, AstraZeneca.
MetricBioNTechAstraZeneca
Market Cap--
Revenue$114.00M$15.38B
Cost of Revenue$105.00M$2.52B
Gross Profit$9.00M$12.86B
Operating Income$-1.02B$3.16B
Net Income$-886.00M$2.51B
R&D Expense$595.00M$4.05B
Earnings Per Share-$3.5$1.59
Gross Margin8.1%83.6%
Operating Margin-897.8%20.6%
Net Profit Margin-777.3%16.3%
Free Cash Flow$-48.00M$2.13B
Cumulative Free Cash Flow$19.56B$121.22B
Operating Cash Flow$12.00M$2.89B
Cash & Equivalents$10.52B$4.89B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites